ACC胸痛专家共识决策路径的多中心验证
本研究为观察性队列研究,纳入美国5家急诊科成人疑似急性冠脉综合征患者,用ACC专家共识决策路径进行分层。结果显示该路径安全有效,排除区30天死亡或心梗的阴性预测值为99.7%,但在已知冠心病患者中排除区事件率较高,提示该路径在已知冠心病患者中可能不安全。
要点
- ACC路径排除区30天死亡或心梗的阴性预测值为99.7%。
- 在已知冠心病患者中,被划入排除区者30天死亡或心梗发生率为1.5%。
- 该路径在已知冠心病患者中的使用安全性可能不足。
核心结论
- ACC专家共识决策路径安全有效,但在已知冠心病患者中可能不安全。
研究设计与样本
- 观察性队列研究,纳入美国5家急诊科成人疑似急性冠脉综合征患者,最终14,395例完成ACC路径评估。
主要发现
- 14,395例中女性占51.7%,中位年龄56岁,已知冠心病占23.5%,30天死亡或心梗发生率为8.1%。
- ACC路径将48.1%(95%CI:47.3%-49.0%)的患者划入排除区。
- 排除区患者30天死亡或心梗发生率为0.3%(22/6,930),阴性预测值为99.7%(95%CI:99.5%-99.8%)。
- 已知冠心病患者中20.0%(676/3,386)被划入排除区,其中1.5%(10/676)发生30天死亡或心梗。
临床怎么用
- 对疑似急性冠脉综合征患者可应用ACC路径进行分层,但需警惕已知冠心病患者被划入排除区后仍存在一定事件风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The American College of Cardiology (ACC) recently published an Expert Consensus Decision Pathway for chest pain. OBJECTIVES: The purpose of this study was to validate the ACC Pathway in a multisite U.S. METHODS: An observational cohort study of adults with possible acute coronary syndrome was conducted. Patients were accrued from 5 U.S. Emergency Departments (November 1, 2020, to July 31, 2022). ECGs and 0- and 2-hour high-sensitivity troponin (Beckman Coulter) measures were used to stratify patients according to the ACC Pathway. The primary safety outcome was 30-day all-cause death or myocardial infarction (MI). Efficacy was defined as the proportion stratified to the rule-out zone. Negative predictive value for 30-day death or MI was assessed among the whole cohort and in a subgroup of patients with coronary artery disease (CAD) (prior MI, revascularization, or ≥70% coronary stenosis). RESULTS: ACC Pathway assessments were complete in 14,395 patients, of whom 51.7% (7,437 of 14,395) were women with a median age of 56 years (Q1-Q3: 44-68 years). Known CAD was present in 23.5% (3,386 of 14,395) and 30-day death or MI occurred in 8.1% (1,168 of 14,395). The ACC Pathway had an efficacy of 48.1% (95% CI: 47.3%-49.0%). Among patients in the rule-out zone, 0.3% (22 of 6,930) had death or MI at 30 days, yielding a negative predictive value of 99.7% (95% CI: 99.5%-99.8%). In patients with known CAD, 20.0% (676 of 3,386) were classified to the rule-out zone, of whom 1.5% (10 of 676) had death or MI. CONCLUSIONS: The ACC expert consensus decision pathway was safe and efficacious. However, it may not be safe for use among patients with known CAD.
引用
- Mahler, Ashburn, Supples, et al. Validation of the ACC Expert Consensus Decision Pathway for Patients With Chest Pain. J Am Coll Cardiol. 2024. PMID: 38538196. doi:10.1016/j.jacc.2024.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。